Key result
A joint NCI and NHLBI working group identified clinically important research gaps and developed a consensus on priorities for future research in cancer-associated venous thromboembolism.
Answers are grounded in this paper and cite their sources.
This report outlines the consensus research priorities for cancer-associated VTE identified by a joint NCI/NHLBI strategic working group.
The risk for venous thromboembolism (VTE) is increased in cancer and particularly with chemotherapy, and it portends poorer survival among patients with cancer. However, many fundamental questions about cancer-associated VTE, or Trousseau syndrome, remain unanswered. This report summarizes the proceedings of a working group assembled by the NCI and NHLBI in August 2014 to explore the state of the science in cancer-associated VTE, identify clinically important research gaps, and develop consensus on priorities for future research. Representing a convergence of research priorities between the two NIH Institutes, the workshop addressed epidemiologic, basic science, clinical, and translational issues in cancer-associated VTE. Cancer Res; 76(13); 3671-5.
No takes yet. Share an insight, caveat, or question.
Key et al. (2016) conducted a review in Cancer-associated venous thromboembolism (VTE). A joint NCI and NHLBI working group identified clinically important research gaps and developed a consensus on priorities for future research in cancer-associated venous thromboembolism.
Synapse has enriched 10 related papers. Consider them for comparative context: